Identification of molecular links between osteoarthritis and lipid metabolism
Osteoarthritis is a multifactorial disease characterized by destruction of the articular cartilage due to genetic, mechanical and environmental components affecting more than 100 million individuals all over the world. Despite the high prevalence of the disease, the absence of large-scale molecular studies limits our ability to understand the molecular pathobiology of osteoathritis and identify targets for drug development. Our team integrated genetic, bioinformatic and proteomic approaches in order to identify new genes and their collaborative networks involved in osteoarthritis pathogenesis. Integration of microRNA and proteomic data, generated a potential “interactome” network consisting of 11 microRNAs and 58 proteins linked by 414 potential functional associations. Comparison of the molecular and clinical data, revealed specific microRNAs (miR-22, miR-103) and proteins (PPARA, BMP7, IL1B) to be highly correlated with Body Mass Index (BMI). Experimental validation revealed that miR-22 regulated PPARA and BMP7 expression and its inhibition blocked inflammatory and catabolic changes in osteoarthritic chondrocytes. Our findings indicate that obesity and inflammation are related to osteoarthritis, a metabolic disease affected by microRNA deregulation. Gene network approaches provide new insights for elucidating the complexity of diseases such as osteoarthritis. The integration of microRNA, proteomic and clinical data provides a detailed picture of how a network state is correlated with disease and furthermore leads to the development of new treatments. This strategy will help to improve the understanding of the pathogenesis of multifactorial diseases such as osteoarthritis and provide possible novel therapeutic targets.
A. Central role of SREBP-2 in the pathogenesis ofosteoarthritis. Kostopoulou F, Gkretsi V, Malizos KN, Iliopoulos D, Oikonomou P, Poultsides L, Tsezou A. PLoS One. 2012;7(5):e35753.
B. Proteomics of osteoarthritic chondrocytes and cartilage. Iliopoulos D, Gkretsi V, Tsezou A. Expert Rev Proteomics. 2010 Oct;7(5):749-60.
C. Involvement of SOX-9 and FGF-23 in RUNX-2 regulation in osteoarthritic chondrocytes. Orfanidou T,Iliopoulos D, Malizos KN, Tsezou A. J Cell Mol Med. 2009 Sep;13(9B):3186-94.
D. Impaired expression of genes regulating cholesterol efflux in human osteoarthritic chondrocytes. Tsezou A,Iliopoulos D, Malizos KN, Simopoulou T. J Orthop Res. 2010 Aug; 28(8):1033-9.
E. Integrative microRNA and proteomic approaches identify novelosteoarthritis genes and their collaborative metabolic and inflammatory networks. Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A. PLoS One. 2008;3(11):e3740.
F. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target forosteoarthritis therapeutic intervention. Iliopoulos D, Malizos KN, Tsezou A. Ann Rheum Dis. 2007 Dec;66(12):1616-21.
G. Differential expression of leptin and leptin’s receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Simopoulou T, Malizos KN,Iliopoulos D, Stefanou N, Papatheodorou L, Ioannou M, Tsezou A. Osteoarthritis Cartilage. 2007 Aug;15(8):872-83.